Galderma Investigational Site 6082

Bonn 53127

0 studies enrolling now · 3 studies all time

What they study most

Moderate-to-Severe Atopic Dermatitis, Prurigo Nodularis

Studies at this site

• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis — Completed
• Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed